N.H. Slack

1.8k total citations
35 papers, 1.3k citations indexed

About

N.H. Slack is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, N.H. Slack has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in N.H. Slack's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Bone health and treatments (4 papers). N.H. Slack is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Bone health and treatments (4 papers). N.H. Slack collaborates with scholars based in United States, Switzerland and Canada. N.H. Slack's co-authors include G.P. Murphy, Bernard Fisher, Norman Wolmark, Irwin D. J. Bross, T. Ming Chu, J. Edson Pontes, George R. Prout, S.A. Loening, Robert P. Gibbons and John F. Gaeta and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and CHEST Journal.

In The Last Decade

N.H. Slack

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N.H. Slack United States 22 567 546 417 182 147 35 1.3k
Nelson H. Slack United States 19 723 1.3× 736 1.3× 723 1.7× 364 2.0× 177 1.2× 36 2.0k
Hwee‐Yong Yap United States 18 398 0.7× 765 1.4× 174 0.4× 149 0.8× 97 0.7× 31 1.3k
Nurten Gündüz United States 12 355 0.6× 760 1.4× 692 1.7× 259 1.4× 102 0.7× 14 1.4k
Yeu‐Tsu N. Lee United States 16 341 0.6× 614 1.1× 177 0.4× 113 0.6× 93 0.6× 56 1.1k
Robert M. OʼBryan United States 18 636 1.1× 960 1.8× 212 0.5× 216 1.2× 63 0.4× 44 1.5k
Ellen R. Gaynor United States 22 292 0.5× 751 1.4× 324 0.8× 554 3.0× 140 1.0× 42 1.6k
Reginald P. Pugh United States 19 269 0.5× 581 1.1× 221 0.5× 109 0.6× 50 0.3× 34 1.1k
S.M. O'Reilly United Kingdom 14 294 0.5× 641 1.2× 354 0.8× 137 0.8× 162 1.1× 26 1.2k
Rose J. Papac United States 19 377 0.7× 647 1.2× 164 0.4× 136 0.7× 67 0.5× 49 1.5k
H. C. Falkson South Africa 16 199 0.4× 608 1.1× 349 0.8× 138 0.8× 43 0.3× 32 1.0k

Countries citing papers authored by N.H. Slack

Since Specialization
Citations

This map shows the geographic impact of N.H. Slack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.H. Slack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.H. Slack more than expected).

Fields of papers citing papers by N.H. Slack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.H. Slack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.H. Slack. The network helps show where N.H. Slack may publish in the future.

Co-authorship network of co-authors of N.H. Slack

This figure shows the co-authorship network connecting the top 25 collaborators of N.H. Slack. A scholar is included among the top collaborators of N.H. Slack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N.H. Slack. N.H. Slack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zalutsky, Michael R., et al.. (1990). Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis. British Journal of Cancer. 62(4). 637–642. 47 indexed citations
2.
Cosgrove, David O., et al.. (1986). Focal sparing in fatty infiltration of the liver. British Journal of Radiology. 59(697). 25–28. 21 indexed citations
3.
Gibbons, Robert P., S. Beckley, Mark F. Brady, et al.. (1983). The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate. Journal of Surgical Oncology. 23(2). 133–142. 11 indexed citations
4.
Slack, N.H., et al.. (1983). Prostatic Carcinoma Treated at a Categorical Center. The Journal of Urology. 130(4). 830–830. 8 indexed citations
5.
6.
Pontes, J. Edson, et al.. (1982). Serum Prostatic Antigen Measurement in Localized Prostatic Cancer: Correlation with Clinical Course. The Journal of Urology. 128(6). 1216–1218. 44 indexed citations
7.
8.
Slack, N.H., James P. Karr, T. Ming Chu, & G.P. Murphy. (1980). An assessment of bone scans for monitoring osseous metastases in patients being treated for prostate carcinoma. The Prostate. 1(2). 259–270. 17 indexed citations
9.
Beckley, S., Zev Wajsman, N.H. Slack, A Mittelman, & Murphy Gp. (1980). The chemotherapy of prostatic carcinoma.. PubMed. 55. 151–62. 1 indexed citations
10.
Killian, C. S., et al.. (1980). Solid‐phase immunofluorescent and immunoadsorbent assays of serum prostatic acid phosphatase. The Prostate. 1(4). 427–439. 7 indexed citations
11.
Chu, T. Ming, et al.. (1980). Value of new fluorescent immunoassay for human prostatc acid phosphatase in prostate cancer. Urology. 15(4). 338–341. 23 indexed citations
12.
Beckley, S., Chu Tm, Zew Wajsman, et al.. (1980). Modern concepts of acid and alkaline phosphatase measurement.. PubMed. 55. 65–70. 2 indexed citations
13.
Murphy, G.P. & N.H. Slack. (1980). Response criteria for the prostate of the USA national prostatic cancer project. The Prostate. 1(3). 375–382. 83 indexed citations
14.
Slack, N.H. & Irwin D. J. Bross. (1975). The influence of site of metastasis on tumour growth and response to chemotherapy. British Journal of Cancer. 32(1). 78–86. 46 indexed citations
15.
Fisher, Bernard, et al.. (1975). Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.. PubMed. 140(4). 528–34. 276 indexed citations
16.
Ravdin, Robert G., Edward F. Lewison, N.H. Slack, et al.. (1970). Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma.. PubMed. 131(6). 1055–64. 86 indexed citations
17.
Slack, N.H., Leslie E. Blumenson, & Irwin D. J. Bross. (1969). Therapeutic implications from a mathematical model characterizing the course of breast cancer. Cancer. 24(5). 960–971. 43 indexed citations
18.
Moore, G. E., Irwin D. J. Bross, Robert K. Ausman, et al.. (1968). Effects of 6-mercaptopurine (NSC-755) in 290 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.. PubMed. 52(6). 655–60. 9 indexed citations
19.
Ge, Moore, et al.. (1968). Effects of chlorambucil (NSC-3088) in 374 patients with advanced cancer. Eastern Clinical Drug Evualuation Program.. PubMed. 52(6). 661–6. 24 indexed citations
20.
Moore, G. E., Irwin D. J. Bross, Robert K. Ausman, et al.. (1968). Effects of mitomycin c (NSC-26980) in 346 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.. PubMed. 52(6). 675–84. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nelson H. Slack Breakdown of academic impact, for papers by Hwee‐Yong Yap Breakdown of academic impact, for papers by Nurten Gündüz Breakdown of academic impact, for papers by Yeu‐Tsu N. Lee Breakdown of academic impact, for papers by Robert M. OʼBryan Breakdown of academic impact, for papers by Ellen R. Gaynor Breakdown of academic impact, for papers by Reginald P. Pugh Breakdown of academic impact, for papers by S.M. O'Reilly Breakdown of academic impact, for papers by Rose J. Papac Breakdown of academic impact, for papers by H. C. Falkson
Rankless by CCL
2026